A Pregnancy Case of Primary Mediastinal Large B Cell Lymphoma with Superior Vena Cava Syndrome

Primary mediastinal large B cell lymphoma (PMLBCL) is a subtype of non-Hodgkin's lymphoma which presents rarely in pregnancy. It is an aggressive tumour that is associated with symptoms of superior vena cava (SVC) compression and airway compromise such as dyspnoea, facial and arm swelling, coug...

Full description

Saved in:
Bibliographic Details
Main Authors: Lauren Brownhalls (Author), Ann Gillett (Author), Yasmin Whately (Author), Keisuke Tanaka (Author)
Format: Book
Published: Hindawi Limited, 2021-01-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_cd3faa3f8cc74bf195b51c23e5f43981
042 |a dc 
100 1 0 |a Lauren Brownhalls  |e author 
700 1 0 |a Ann Gillett  |e author 
700 1 0 |a Yasmin Whately  |e author 
700 1 0 |a Keisuke Tanaka  |e author 
245 0 0 |a A Pregnancy Case of Primary Mediastinal Large B Cell Lymphoma with Superior Vena Cava Syndrome 
260 |b Hindawi Limited,   |c 2021-01-01T00:00:00Z. 
500 |a 2090-6692 
500 |a 10.1155/2021/3438230 
520 |a Primary mediastinal large B cell lymphoma (PMLBCL) is a subtype of non-Hodgkin's lymphoma which presents rarely in pregnancy. It is an aggressive tumour that is associated with symptoms of superior vena cava (SVC) compression and airway compromise such as dyspnoea, facial and arm swelling, cough, or chest pain. Timely diagnosis is imperative to optimising patient outcomes and reducing both maternal and fetal morbidity and mortality. We report a case of a 33-year-old woman diagnosed with PMLBCL who presented at 33-week gestation with SVC obstruction to 1 mm in diameter. After multidisciplinary team discussion regarding maternal and fetal implications of management options, we proceeded to a caesarean section and initiated chemotherapy postdelivery. Lower segment caesarean section was uncomplicated, and she underwent a cycle of R-CHOEP followed by 5 cycles of DA-EPOCH. Eighteen months since the completion of the chemotherapy, the disease remained in remission. 
546 |a EN 
690 |a Gynecology and obstetrics 
690 |a RG1-991 
655 7 |a article  |2 local 
786 0 |n Case Reports in Obstetrics and Gynecology, Vol 2021 (2021) 
787 0 |n http://dx.doi.org/10.1155/2021/3438230 
787 0 |n https://doaj.org/toc/2090-6692 
856 4 1 |u https://doaj.org/article/cd3faa3f8cc74bf195b51c23e5f43981  |z Connect to this object online.